Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Devlin

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Biochemical Journal|March 15, 1979
Regulation of mammalian protein synthesis in vivo. Simulated transport of nuclear ribonucleoprotein complexes to the cytoplasm after cycloheximide treatmentJ J Ch'ih, D M Duhl, L S Faulkner, et al.
Biochemical Pharmacology|April 15, 1988
Modification of protein synthetic components by aflatoxin B1B A Lyman, L Erki, D W Biedrzycka, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1989
2(3)-tert-butyl-4-hydroxyanisole inhibits oxidative metabolism of aflatoxin B1 in isolated rat hepatocytesJ J Ch'ih, D W Biedrzycka, T Lin, et al.
European Journal of Pharmacology|March 16, 1993
MK-801 is neuroprotective but does not improve survival in severe forebrain ischemiaD K Von Lubitz, R J McKenzie, R C Lin, et al.
European Journal of Pharmacology|May 27, 1992
Treatment of severe brain ischemia with di- and tri-Calciphor (dimer and trimer of 16,16'-dimethyl prostaglandin B1)D K Von Lubitz, R J McKenzie, A Kalenak, et al.
Brain Research|March 19, 1993
Neuroprotective activity of dimer of 16,16'-dimethyl-15-dehydroprostaglandin B1 (di-Calciphor) in cerebral ischemiaR C Lin, D F Matesic, R J McKenzie, et al.
European Journal of Pharmacology|August 14, 1992
A novel treatment of global cerebral ischaemia with a glycine partial agonistD K Von Lubitz, R C Lin, R J McKenzie, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Biochemical Journal|March 15, 1979
Regulation of mammalian protein synthesis in vivo. Simulated transport of nuclear ribonucleoprotein complexes to the cytoplasm after cycloheximide treatmentJ J Ch'ih, D M Duhl, L S Faulkner, et al.
Biochemical Pharmacology|April 15, 1988
Modification of protein synthetic components by aflatoxin B1B A Lyman, L Erki, D W Biedrzycka, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1989
2(3)-tert-butyl-4-hydroxyanisole inhibits oxidative metabolism of aflatoxin B1 in isolated rat hepatocytesJ J Ch'ih, D W Biedrzycka, T Lin, et al.
European Journal of Pharmacology|March 16, 1993
MK-801 is neuroprotective but does not improve survival in severe forebrain ischemiaD K Von Lubitz, R J McKenzie, R C Lin, et al.
European Journal of Pharmacology|May 27, 1992
Treatment of severe brain ischemia with di- and tri-Calciphor (dimer and trimer of 16,16'-dimethyl prostaglandin B1)D K Von Lubitz, R J McKenzie, A Kalenak, et al.
Brain Research|March 19, 1993
Neuroprotective activity of dimer of 16,16'-dimethyl-15-dehydroprostaglandin B1 (di-Calciphor) in cerebral ischemiaR C Lin, D F Matesic, R J McKenzie, et al.
European Journal of Pharmacology|August 14, 1992
A novel treatment of global cerebral ischaemia with a glycine partial agonistD K Von Lubitz, R C Lin, R J McKenzie, et al.
Pageof 4